Trial Profile
A Phase 2A, Single-Dose, Double-Blind Placebo-Controlled, 2-Way Crossover Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Female sexual dysfunction
- Focus Therapeutic Use
- Sponsors Strategic Science & Technologies
- 19 Feb 2018 New trial record